$BCAX
Bicara Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
BCAX chart
What traders are saying about $BCAX
Latest postsBicara Therapeutics Inc. news
- Stifel Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $45
Moomoo ·
- Bicara Therapeutics Inc. Estimates – NASDAQ:BCAX
TradingView ·
- Biocon Succession Plan: Kiran Mazumdar-Shaw Names Claire Mazumdar As Future Leader
Goodreturns ·
- Bicara Therapeutics (BCAX) Options Chain & Prices 2026
MarketBeat ·
- Bicara Therapeutics (BCAX) Slips 2.40% to $17.91 as Shares Test Lower Support Zone - Insider Selling Alerts
https://www.dars.gov.et/ ·
- Morgan Stanley Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Raises Target Price to $41
富途牛牛 ·
- Form 144 BICARA THERAPEUTICS INC. For: 21 October By Investing.com
Investing.com Canada ·
- Bicara Therapeutics (BCAX) Stock May Look Overvalued On Book Value
Yahoo Finance ·
- Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Can Bicara (BCAX) Commercialize Ficera? Breakthrough 3-Year Data Faces Execution Risk in C-Suite Overhaul
Yahoo Finance ·
- Bicara Therapeutics (BCAX) Q2 2026 Earnings Call Transcript
fool.com ·
- Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
Bicara Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$137.9M | -$68.0M | -$52.0M |
| Diluted EPS | $-2.52 | $-4.05 | $-89.61 |
| Total assets (year end) | $431.0M | $510.0M | $234.0M |
| Cash and equivalents (year end) | $96.7M | $489.7M | $230.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bicara Therapeutics Inc.
- Ticker
- BCAX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2023658
Frequently asked questions
What exchange is Bicara Therapeutics Inc. listed on?
Bicara Therapeutics Inc. trades on the Nasdaq under the ticker symbol BCAX.
What industry is Bicara Therapeutics Inc. in?
Bicara Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Bicara Therapeutics Inc. headquartered?
Bicara Therapeutics Inc.'s business address on file with the SEC is in Boston, MA.
When does Bicara Therapeutics Inc.'s fiscal year end?
Bicara Therapeutics Inc.'s fiscal year ends on December 31.